Table 1.
Correlation of LIPH expression to clinicopathological features in PC
| Parameters | LIPH expression | P | |
|---|---|---|---|
| Low (n = 27) | High (n = 144) | ||
| Age | |||
| ≦60 | 9 (33.3%) | 48 (33.3%) | 1.00 |
| > 60 | 18 (66.7%) | 96 (66.7%) | |
| Gender | |||
| Female | 13 (48.1%) | 65 (45.1%) | 0.77 |
| Male | 14 (51.9%) | 79 (54.9%) | |
| AJCC stage | |||
| I–IIa | 9 (33.3%) | 38 (26.4%) | 0.33 |
| IIb–IV | 16 (59.3%) | 105 (72.9%) | |
| Unknown | 2 (7.4%) | 1 (0.7%) | |
| Histologic grade | |||
| G1 | 11 (40.7%) | 17 (11.8%) | 0.000008**** |
| G2 | 10 (37.0%) | 82 (56.9%) | |
| G3 | 3 (11.1%) | 44 (30.6%) | |
| G4 | 2 (7.4%) | 0 | |
| Unknown | 1 (3.7%) | 1 (0.7%) | |
| Recurrence | |||
| No | 18 (66.7%) | 48 (33.3%) | 0.001** |
| Yes | 9 (33.3%) | 96 (66.7%) | |
| Alcohol history | |||
| No | 10 (37.0%) | 52 (36.1%) | 0.99 |
| Yes | 15 (55.6%) | 82 (56.9%) | |
| Unknown | 2 (7.4%) | 10 (6.9%) | |
| Diabetes history | |||
| No | 16 (59.3%) | 89 (61.8%) | 0.77 |
| Yes | 5 (18.5%) | 31 (21.5%) | |
| Unknown | 6 (22.2%) | 24 (16.7%) | |
| Tumor size | |||
| < 4 | 17 (63.0%) | 73 (50.7%) | 0.21 |
| ≧4 | 10 (37.0%) | 58 (40.3%) | |
| Unknown | 0 | 13 (9.0%) | |
| Tumor site | |||
| Head | 17 (63.0%) | 116 (80.6%) | 0.07 |
| Body and tail | 21 (77.8%) | 6 (4.2%) | |
| Unknown | 7 (25.9%) | 4 2.8%) | |
Statistical significance was calculated by the chi-square test and Fisher’s extract test